us

BioGaia AB (publ) BIOGY Stock

$12.36   0.000000%
Add to favorites
Market Cap
$1.25B
LOW - HIGH [24H]
$12.36 - $12.36
VOLUME [24H]
$100.00
P/E Ratio
34.33
Earnings per share
$0.36
ISIN
US09072J1025
Price   Prediction

BioGaia AB (publ) Price Chart

Sorry, that's all we've gotfor now...

BioGaia AB (publ) BIOGY Financial and Trading Overview

BioGaia AB (publ) stock price 12.36 USD
Previous Close 12.36 USD
Open 12.36 USD
Bid 9.5 USD x 30000
Ask 12.11 USD x 10000
Day's Range 12.36 - 12.36 USD
52 Week Range 8.79 - 12.36 USD
Volume 100 USD
Avg. Volume 6 USD
Market Cap 1.25B USD
Beta (5Y Monthly) 0.319
PE Ratio (TTM) 34.333332
EPS (TTM) 0.36 USD
Forward Dividend & Yield 0.42 (3.41%)
Ex-Dividend Date May 11, 2026
1y Target Est N/A

BIOGY Valuation Measures

Enterprise Value N/A
Trailing P/E 34.333332
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 1.0265781
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

BioGaia AB (publ) Stock Price History

Beta (5Y Monthly) 0.319
52-Week Change 26.76%
S&P500 52-Week Change 19.78%
52 Week High 12.36 USD
52 Week Low 8.79 USD
50-Day Moving Average 11.08 USD
200-Day Moving Average 10.85 USD

BIOGY Share Statistics

Avg. Volume (3 month) 6 USD
Avg. Daily Volume (10-Days) 40 USD
Shares Outstanding 98.5M
Float 83.94M
Short Ratio N/A
% Held by Insiders 0%
% Held by Institutions 0.029%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 1.1411
Last Split Factor 2499:1000

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) June 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 21.96%
Operating Margin (ttm) 0%
Gross Margin 73.00%
EBITDA Margin 28.76%

Management Effectiveness

Return on Assets (ttm) 19.76%
Return on Equity (ttm) 30.78%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) 8.90%
Gross Profit (ttm) N/A
EBITDA 454.58M USD
Net Income Avi to Common (ttm) N/A
Diluted EPS (ttm) 0.36
Quarterly Earnings Growth (yoy) 17.39%

Balance Sheet

Total Cash (mrq) N/A
Total Cash Per Share (mrq) N/A
Total Debt (mrq) N/A
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 4.443
Book Value Per Share (mrq) 12.04

Cash Flow Statement

Operating Cash Flow (ttm) N/A
Levered Free Cash Flow (ttm) 228.55M USD

Profile of BioGaia AB (publ)

Country United States
State N/A
City Stockholm
Address Kungsbroplan 3
ZIP 112 27
Phone 46 8 55 52 93 00
Website https://www.biogaiagroup.com
Industry Drug Manufacturers - Specialty & Generic
Sector(s) Healthcare
Full Time Employees 251

BioGaia AB (publ), a healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula and milk formula. Its Adult Health segment provides gut health tablets, bone health tablets, and oral health lozenges, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment offers packaging solutions. It sells its products through distribution partners or through its own distribution channels. The company was incorporated in 1990 and is headquartered in Stockholm, Sweden.

Q&A For BioGaia AB (publ) Stock

What is a current BIOGY stock price?

BioGaia AB (publ) BIOGY stock price today per share is 12.36 USD.

How to purchase BioGaia AB (publ) stock?

You can buy BIOGY shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for BioGaia AB (publ)?

The stock symbol or ticker of BioGaia AB (publ) is BIOGY.

Which industry does the BioGaia AB (publ) company belong to?

The BioGaia AB (publ) industry is Drug Manufacturers - Specialty & Generic.

How many shares does BioGaia AB (publ) have in circulation?

The max supply of BioGaia AB (publ) shares is 101.16M.

What is BioGaia AB (publ) Price to Earnings Ratio (PE Ratio)?

BioGaia AB (publ) PE Ratio is 34.33333200 now.

What was BioGaia AB (publ) earnings per share over the trailing 12 months (TTM)?

BioGaia AB (publ) EPS is 0.36 USD over the trailing 12 months.

Which sector does the BioGaia AB (publ) company belong to?

The BioGaia AB (publ) sector is Healthcare.

$2.29T
Total marketcap
$54.11B
Total volume
BTC 56.61%     ETH 10.08%
Dominance
Select currency